MedTrace Logo

Ex Vivo Normothermic Perfusion in Kidney Transplantation.

NCT05175885 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-11-12

No results posted yet for this study

Summary

A multicenter, prospective and open-label clinical investigation to evaluate the viability, performance and safety of ex vivo normothermic perfusion in kidney transplantation from DCD and DBD donors.

Conditions

  • Kidney Transplantation

Interventions

DEVICE

Ex vivo normothermic perfusion

Ex vivo normothermic perfusion (EVNP) of the renal graft with the Ark Kidney System

DEVICE

Cold preservation

Static cold storage (SCS) or hypothermic machine perfusion (HMP) of the renal graft

Sponsors & Collaborators

  • Ebers Medical Technology, S.L.

    lead INDUSTRY

Principal Investigators

  • Alex Gutierrez-Dalmau, MD · Miguel Servet University Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-14
Primary Completion
2025-12-31
Completion
2027-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05175885 on ClinicalTrials.gov